Almirall Investor Relations Material
Latest events
Q4 2023
Almirall
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Almirall S.A.
Access all reports
Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines. The company offers dermatological products that are used in the treatment of acne, psoriasis and other inflammatory skin diseases; aesthetic products that are used in the treatment of hair loss and to promote hair regrowth; and treating and preventing the excessive growth of sebaceous glands in adults, children and infants. Its products include Epiduo, Avage, Atralin Topical Solution, Acnomel Cream, Oustiderm Scalp Lotion, Tazorac Gel and Others.
Key slides for Almirall S.A.
Q2 2023
Almirall S.A.
Q4 2023
Almirall S.A.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇪🇸 Spain